CSC-derived peptides, including EpCAM peptides used as antigen sources for dendritic cell (DC) vaccination, induce EpCAM peptide-specific cytotoxic T lymphocytes (CTLs) with potent cytotoxic activity against EpCAM-positive HCC cells [142]. Here, EPCAM is linked to hepatocellular carcinoma.